Viemed Healthcare, Inc. (VMD)

Viemed Healthcare Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	13.98	11.27	10.24	6.22	9.13	31.53
Depreciation & Amortization	26.28	25.37	21.86	15.63	11.31	9.58
Other Amortization	0.17	0.19	-	-	-	-
Loss (Gain) From Sale of Assets	-4.58	-1.91	0.65	0.35	0.45	-2.33
Loss (Gain) From Sale of Investments	0.13	1.34	-0.22	-	-	-
Loss (Gain) on Equity Investments	-	-0.11	0.5	0.14	-0.83	-0.09
Stock-Based Compensation	7.89	6.29	5.85	5.2	5.15	4.88
Provision & Write-off of Bad Debts	-	-	-	-	6.9	9.12
Other Operating Activities	-5.49	-3.7	-1.44	0.33	3.95	-7.38
Change in Accounts Receivable	0.51	-6.07	-1.06	-2.56	-7.35	-9.96
Change in Inventory	0.1	0.57	-0.47	0.3	-0.21	-2.3
Change in Accounts Payable	0.84	0.36	-0.86	-0.32	0.13	0.21
Change in Unearned Revenue	0.47	0.36	0.85	0.87	0.34	0.09
Change in Income Taxes	1.9	1.73	2.18	1.87	-2.23	0.25
Change in Other Net Operating Assets	0.65	3.4	7.14	-0.29	-4.25	1.5
Operating Cash Flow	42.84	39.09	45.21	27.75	22.49	35.11
Operating Cash Flow Growth	11.42%	-13.54%	62.94%	23.36%	-35.93%	83.95%
Capital Expenditures	-46.44	-37.77	-26.09	-22.9	-19.74	-13.04
Sale of Property, Plant & Equipment	22.27	10.32	2.59	1.06	0.6	5.26
Cash Acquisitions	-	-3	-28.59	-	-	-
Investment in Securities	-0.25	-0.25	-0.02	-2.14	-0.6	-0.63
Investing Cash Flow	-24.42	-30.7	-52.11	-23.98	-19.75	-8.42
Long-Term Debt Issued	-	3	13	-	-	-
Long-Term Debt Repaid	-	-6.41	-10.88	-5.84	-4	-10.95
Net Debt Issued (Repaid)	-5.61	-3.41	2.12	-5.84	-4	-10.95
Issuance of Common Stock	2.06	1.02	1.3	0.28	0.11	1.88
Repurchase of Common Stock	-3.39	-1.07	-0.59	-9.71	-1.43	-
Other Financing Activities	-0.27	-0.23	-	-	-	-
Financing Cash Flow	-7.21	-3.69	2.83	-15.27	-5.32	-9.07
Net Cash Flow	11.21	4.7	-4.08	-11.49	-2.57	17.63
Free Cash Flow	-3.6	1.32	19.12	4.85	2.75	22.07
Free Cash Flow Growth	-	-93.11%	294.21%	76.30%	-87.53%	286.99%
Free Cash Flow Margin	-1.50%	0.59%	10.45%	3.49%	2.35%	16.80%
Free Cash Flow Per Share	-0.09	0.03	0.47	0.12	0.07	0.54
Cash Interest Paid	0.65	0.95	0.85	0.23	0.35	0.56
Cash Income Tax Paid	10.05	6.83	3.57	-0.85	1.77	3.31
Levered Free Cash Flow	6.37	2.22	22.29	3.95	0.43	18.09
Unlevered Free Cash Flow	6.63	2.52	22.55	4.07	0.63	18.4
Change in Working Capital	4.48	0.36	7.78	-0.12	-13.56	-10.2

Updated May 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q